FBB
IONS icon

Fulton Breakefield Broenniman’s Ionis Pharmaceuticals IONS Stock Holding History

Fulton Breakefield Broenniman’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,775
Closed -$409K – 168
2019
Q4 		$409K Buy
+6,775
New +$404K 0.05% 132

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fulton Breakefield Broenniman's IONS Position: Q1 2020 in Review

Fulton Breakefield Broenniman sold out of Ionis Pharmaceuticals (IONS) in Q1 2020, closing a stake of 6,775 shares — an estimated $409K sold.

Fulton Breakefield Broenniman first reported a position in IONS in Q4 2019 and held it in 1 quarter. The position peaked at $409K in Q4 2019. 362 funds tracked by Wall St. Rank hold IONS as of Q1 2020.

  • Fulton Breakefield Broenniman reported no remaining Ionis Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Fulton Breakefield Broenniman sold 6,775 Ionis Pharmaceuticals shares in Q1 2020, an estimated $409K.
  • Fulton Breakefield Broenniman first reported a position in Ionis Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • Fulton Breakefield Broenniman's Ionis Pharmaceuticals position peaked at $409K in Q4 2019.
  • 362 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2020.

Based on Fulton Breakefield Broenniman's 13F filing for Q1 2020, filed 10 Apr 2020.